Literature DB >> 34671578

Fulminant Haemolysis Following Endoscopic Retrograde Cholangiopancreatography.

Mário Bibi1, Susana Viana1, Cátia Leitão2, Rui Moço1, Yuliana O Eremina3,4.   

Abstract

We report the case of a 77-year-old-man with a history of type 2 diabetes mellitus who underwent endoscopic retrograde cholangiopancreatography (ERCP) because of a gallstone in the common bile duct. Thirty-six hours after the procedure, the patient developed persistent fever and epigastric pain associated with de novo jaundice. Massive haemolysis (with exuberant spherocytosis) occurred and patient died in 3 hours. Clostridium perfringens was isolated in the blood cultures. Massive haemolysis associated with C. perfringens has a high mortality rate. Management involves a high index of suspicion after gastrointestinal procedures like ERCP, surgical consultation, antibiotic therapy, transfusion of red cell concentrates and, potentially, hyperbaric oxygen therapy. LEARNING POINTS: Endoscopic retrograde cholangiopancreatography (ERCP) can be complicated by Clostridium perfringens bacteraemia with devastating consequences.C. perfringens infection should be suspected in an icteric, febrile patient with abdominal pain, especially if intravascular haemolysis is present.Management of intravascular haemolysis and inflammation in a patient following ERCP should be multidisciplinary, involving surgery when needed and potentially hyperbaric oxygen therapy; penicillin or penicillin-derived antibiotics associated with clindamycin or metronidazole are the mainstays of antibiotic therapy. © EFIM 2021.

Entities:  

Keywords:  Clostridium perfringens; endoscopic retrograde cholangiopancreatography; haemolysis; sepsis; spherocytosis

Year:  2021        PMID: 34671578      PMCID: PMC8523371          DOI: 10.12890/2021_002811

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  5 in total

1.  Massive hemolysis due to Clostridium perfringens: a laboratory's perspective.

Authors:  Bob Smit; Marinke W van der Helm; Madeleen Bosma; Francisca Hudig; Henk Russcher
Journal:  Clin Chem Lab Med       Date:  2020-10-25       Impact factor: 3.694

2.  Massive intravascular hemolysis from Clostridium perfringens septicemia: a review.

Authors:  Tracey G Simon; Joanna Bradley; Adisa Jones; Gerardo Carino
Journal:  J Intensive Care Med       Date:  2013-09-09       Impact factor: 3.510

3.  Massive haemolysis, gas-forming liver abscess and sepsis due to Clostridium perfringens bacteraemia.

Authors:  Rafael García Carretero; Marta Romero Brugera; Oscar Vazquez-Gomez; Noelia Rebollo-Aparicio
Journal:  BMJ Case Rep       Date:  2016-11-25

4.  Emphysematous Cholecystitis Resulting in Secondary Biliary Cirrhosis: A Rare Complication of Endoscopic Retrograde Cholangiopancreatography.

Authors:  Khurram Bari; Harry R Aslanian; Jeffrey Pollak; Eric Reiner; Ronald R Salem; Tamar H Taddei; Sukru H Emre; Priya A Jamidar
Journal:  ACG Case Rep J       Date:  2013-10-08

5.  Clostridium Perfringens Infection in a Febrile Patient with Severe Hemolytic Anemia.

Authors:  Masamitsu Hashiba; Atsutoshi Tomino; Nobuyoshi Takenaka; Tomonori Hattori; Hideki Kano; Masanobu Tsuda; Naoshi Takeyama
Journal:  Am J Case Rep       Date:  2016-04-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.